Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biohaven Pharmaceutical Holding Ltd (BHVN)

Biohaven Pharmaceutical Holding Ltd (BHVN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,916,097
  • Shares Outstanding, K 70,527
  • Annual Sales, $ 462,510 K
  • Annual Income, $ -846,590 K
  • 60-Month Beta 1.20
  • Price/Sales 21.50
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BHVN with:

Options Overview Details

View History
  • Implied Volatility 8.29% ( -1.40%)
  • Historical Volatility 165.92%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 106.00% on 05/09/22
  • IV Low 8.29% on 05/17/22
  • Put/Call Vol Ratio 0.19
  • Today's Volume 1,475
  • Volume Avg (30-Day) 1,752
  • Put/Call OI Ratio 1.12
  • Today's Open Interest 28,305
  • Open Int (30-Day) 16,563

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -2.30
  • Number of Estimates 5
  • High Estimate -1.94
  • Low Estimate -2.67
  • Prior Year -3.23
  • Growth Rate Est. (year over year) +28.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
79.01 +79.45%
on 04/29/22
144.00 -1.54%
on 05/10/22
+30.90 (+27.87%)
since 04/14/22
3-Month
79.01 +79.45%
on 04/29/22
144.00 -1.54%
on 05/10/22
+0.84 (+0.60%)
since 02/17/22
52-Week
69.51 +103.97%
on 05/19/21
151.51 -6.42%
on 10/05/21
+71.51 (+101.76%)
since 05/17/21

Most Recent Stories

More News
BIOHAVEN INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Biohaven Pharmaceutical Holding Company Ltd. - BHVN

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Biohaven Pharmaceutical Holding Company Ltd....

BHVN : 141.78 (+0.84%)
PFE : 51.34 (+1.32%)
The Zacks Analyst Blog Highlights Regeneron, Vertex, Intercept Pharmaceuticals, and Biohaven Pharmaceutical

Regeneron, Vertex, Intercept Pharmaceuticals, and Biohaven Pharmaceutical are part of Zacks top Analyst Blog

REGN : 667.56 (+1.92%)
VRTX : 261.84 (+3.02%)
ICPT : 18.82 (+3.69%)
BHVN : 141.78 (+0.84%)
Biotech Stock Roundup: REGN, VRTX Earnings Update, BHVN Up on Regulatory News

Earnings and regulatory updates from Regeneron (REGN) and Vertex (VRTX) are a few key highlights from the biotech sector during the past week.

REGN : 667.56 (+1.92%)
VRTX : 261.84 (+3.02%)
ICPT : 18.82 (+3.69%)
BHVN : 141.78 (+0.84%)
Biohaven (BHVN) Up on PFE's Buyout Offer, Q1 Loss Wider

Biohaven (BHVN) is set to be acquired by Pfizer (PFE) for $11.6 billion in cash. The transaction is likely to be completed by early 2023. BHVN also reports wider-than-expected Q1 loss.

BMY : 78.22 (+1.70%)
PFE : 51.34 (+1.32%)
ALKS : 29.69 (+2.63%)
BHVN : 141.78 (+0.84%)
Why Biohaven Pharmaceutical Stock Soared Today

An industry titan wants to buy the biotech for a whopping $11.6 billion.

BHVN : 141.78 (+0.84%)
PFE : 51.34 (+1.32%)
2 Extraordinary Events Sent These 2 Stocks Soaring Tuesday

Find out how the rest of the markets are behaving.

COMP : 5.36 (+1.71%)
$DOWI : 32,654.59 (+1.34%)
$SPX : 4,088.85 (+2.02%)
$NASX : 11,984.52 (+2.76%)
APPN : 52.00 (-2.44%)
BHVN : 141.78 (+0.84%)
PEGA : 49.90 (-1.03%)
PFE : 51.34 (+1.32%)
BHVN Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Biohaven Pharmaceutical Holding Company Ltd. Is Fair to Shareholders

Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) to Pfizer Inc. for $148.50 per share in cash is fair to Biohaven...

BHVN : 141.78 (+0.84%)
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Reports Q1 Loss, Tops Revenue Estimates

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) delivered earnings and revenue surprises of -17.86% and 70.40%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies...

BHVN : 141.78 (+0.84%)
ACET : 12.32 (-4.50%)
Pfizer to Acquire Biohaven Pharmaceuticals

Pfizer Inc. (NYSE: PFE) and Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven,...

PFE : 51.34 (+1.32%)
BHVN : 141.78 (+0.84%)
Is a Surprise Coming for Biohaven Pharmaceutical (BHVN) This Earnings Season?

Biohaven Pharmaceutical (BHVN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

BHVN : 141.78 (+0.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Biohaven Pharmaceutical is a commercial-stage biotechnology company focused on developing, and commercializing products, primarily in the fields of central nervous system diseases, including neurological and rare disorders.

See More

Key Turning Points

3rd Resistance Point 143.13
2nd Resistance Point 142.45
1st Resistance Point 142.12
Last Price 141.78
1st Support Level 141.11
2nd Support Level 140.43
3rd Support Level 140.10

See More

52-Week High 151.51
Last Price 141.78
Fibonacci 61.8% 120.19
Fibonacci 50% 110.51
Fibonacci 38.2% 100.83
52-Week Low 69.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar